Effects of Sleep Disorders Increase During Pregnancy

A research study focused on ‘Sleep and vigilance disorders in pregnancy’ revealed that the overall effect of sleep disorders increase during all trimesters of pregnancy.The research was conducted at the Department of Neurology, CHU La Miletrie, Poitiers, France.

Objectives of this study included evaluation of frequency of sleep disorders like sleep apnea disorder, insomnia, restless leg syndrome, and daytime sleepiness according to three defined trimesters of pregnancy. In orders to study and evaluate the effects of sleep disorders like sleep apnea and daytime sleepiness researchers selected 871 young pregnant women on random basis.

The research study was based on a cross-sectional design and included retrospective survey of pre-pregnancy stage, symptoms, and prospective survey of current symptoms. Researchers used questionnaires and interviews to derive inferences. Alterations in the sleeping patterns of mothers were analyzed to evaluate their sleep before pregnancy and sleeping patterns during different trimesters of pregnancy. Read the rest of this entry

Stimulation Therapy For Sleep Apnea Trials

The University Hospitals Case Medical Center is conducting  research study and clinical trials  for evaluating effectiveness of a new implantable device to treat sleep apnea.

The study is aimed to evaluate an electronic device designed to deliver mild stimulation to the main nerve of the tongue — the hypoglossal nerve — on each breathing cycle during sleep.

This stimulation is intended to restore tone to the muscles that control the base of the tongue, which prevent the tongue from collapsing and obstructing the airway during sleep.

Sleep apnea obstruction may not be the only cause for loud snoring but it does affects sleep that is not refreshing. At the same time sleep apnea equally causes daytime sleepiness and a reduced quality of life. Other disorders associated with sleep apnea include development of high blood pressure, as well as cardiovascular diseases, stroke and diabetes. Read the rest of this entry

How Much Sleep Do You Need ?

Getting too much sleep is hazardous to your health — it may lead to  higher risk for obesity, diabetes, and premature death. We’ve been brainwashed  to think we need 8 hours of sleep a night, but sleep requirements vary greatly  by age, stress level, and health. In fact, research suggests 7  hours might be the ideal amount of sleep the average adult needs per night, and  getting 8 or more hours can lead to increased mortality — even more so than  too little sleep!

Getting  a good night’s sleep and that “getting a good night’s sleep is the single best  way you never thought of to improve your abilities and human capital literally  overnight. Not only can too much sleep be bad for your health, it can rob you  of your other 8 hours. If you work 8 and sleep 9, that only leaves 7 hours for  you to pursue your goals and live your life. Every hour, minute, and second you  sleep more than you need to is a complete waste of time and your life.  [ Read Complete Post By Robert Pagliarini   …   ]

SleepApneaDisorder/ [Press Release ]/Los Angeles, California /Aviisha Medical Institute, LLC, the  national leader in home sleep care, is inviting the public to attend its  obstructive sleep apnea (OSA) webinars. The webinars are broadcasted live on the  first Monday of every month at 1pm PST. They webinars are hosted by Dr. Avi  Ishaaya and cover a broad range of topics related to sleep apnea. Dr. Avi is a  board-certified pulmonologist who specializes in treating sleep disorders. He is  the one of nation’s foremost experts on sleep issues and has been featured in  Newsweek and the Wall Street Journal.

The webinars were originally designed for physicians in Aviisha’s MD Home  Sleep Program (www.aviisha.com/mdhsp),  but interest and demand have changed that. “The webinars are a great way for all  people to learn about sleep apnea,” said Dr. Avi. “Sleep apnea carries serious  consequences for sufferers as well as their partners. Its prevalence is rising  dramatically yet only 10-20% of sufferers are diagnosed. We hope that opening  these webinars to the public can help raise awareness.” Read the rest of this entry

Vendor Fair At Edward Sleep Center

The Edward Sleep Center A.W.A.K.E. (Alert, Well And Keeping Energetic) support group will host first vendor fair from 6:30 to 8 p.m. Oct. 17 at the Edward Sleep Center, 27555 Diehl Road in Warrenville.

Sleep medicine vendors will be present to provide information about and offer demonstrations of what’s new in the field. The event is open to the public and admission is free.

Sleep apnea patients, family members, physicians and allied health staff are invited to learn about new continuous positive airway pressure equipment, masks and other accessories. Free CPAP machine pressure checks will also be offered. Read the rest of this entry

SleepApneaDisorder/[ Press Release ]/ GLEN BURNIE, Md. /Oct 11, 2011/ NovaSom, Inc., the market leader in technology-driven, payer-aligned cost-saving solutions for obstructive sleep apnea (OSA) management, today announced it has entered a preferred relationship to aid HealthAmerica with managing its sleep disorder diagnostic expenses. Under the agreement, HealthAmerica will direct physicians and patients to the NovaSom(R) Home Sleep Test (HST) instead of in-facility testing for diagnosing OSA, when clinically appropriate. In addition to managing costs, patients overwhelmingly prefer the privacy, convenience and cost savings associated with home testing.HealthAmerica is driving the adoption of home sleep tests as the preferred solution for addressing the OSA epidemic,” said John Wallendjack, MD, Medical Director, HealthAmerica. “NovaSom has invested in clinical content, work flow process and technology solutions to enable us to rationalize OSA diagnosis and redirect testing to the home, when clinically appropriate.” Read the rest of this entry

Innovative sleep apnea compliance solution integrates to leading Continuous Positive Airway Pressure (CPAP) manufacturers.

Umbian Inc. is pleased to announce U-Sleep; the first commercially available, universal CPAP compliance monitoring solution. U-Sleep monitors CPAP device usage, providing critical daily feedback to CPAP users, their employers, sleep specialists and insurance carriers, based on customizable compliance standards.

CPAP devices are commonly used for the treatment of sleep apnea. The monitoring of CPAP device usage encourages regular use and subsequently improves the effectiveness of therapy. As part of an overall sleep apnea management program, U-Sleep can help companies achieve a decrease in absenteeism, accidents and liability while providing an increase in productivity and quality of life for their employees. Read the rest of this entry

SleepApneaDisorder/[ Press Release ]/HOUSTON/Cyberonics, Inc.  a global leader in medical devices for the treatment and management of epilepsy, today announced an initial investment of $4 million in ImThera Medical, Inc. (“ImThera“). Based in San Diego, California, ImThera is an early-stage company developing a novel, implantable neurostimulation device for the treatment of obstructive sleep apnea (“OSA”).

The investment in ImThera can total $12 million subject to the achievement of certain regulatory and clinical milestones. Cyberonics is a minority shareholder with certain rights, including representation on ImThera’s board of directors. In addition, ImThera will raise up to $4 million from its private investors, for a total Series C placement of up to $16 million.

OSA is a serious, potentially life-threatening condition associated with significant long-term health problems and accompanying costs. ImThera’s Targeted Hypoglossal Neurostimulation (THN) Sleep Therapy combines a multi-contact electrode specifically designed to control certain muscles of the tongue with an implantable pulse generator and an external programmer. The company is currently pursuing CE Mark regulatory approval in the European Union and expects to initiate a pivotal clinical trial in the U.S. in the near future. Read the rest of this entry

SleepApneaDisorder/[Press Release]/ Philips Respironics, a unit of Royal Philips Electronics is shaping the future of sleep therapy by providing an innovative technology for treating and managing obstructive sleep apnea (OSA) – in its most advanced CPAP (Continuous Positive Airway Pressure) device to date. The new REMstar Pro with AutoIQ is a prime example of an intelligent solution that allows providers and physicians to deliver exceptional care while helping their patients take control of their sleep therapy.

The new AutoIQ mode has the ability to track a patient’s progress over several nights, establish or readjust to an ideal therapy pressure, and check back periodically to reassess and adjust treatment as needed. This is all done without requiring the provider to visit the patient’s home. Read the rest of this entry

Sleep apnea is a condition that can strike in age groupand in either gender. Although the most common group are older men, children and infants are also at risk. Asthma and sleep apnea are strange bedfellows. Several studies have linked the two issues and theorize that there is a group of people with asthma and sleep apnea who are unaware of the second diagnosis.

Sleep apnea is the description of the condition where the sufferer experiences a temporary, often repeated, pause of breathing during sleep. If a person with sleep apnea has a family member that can observe them they will often witness snoring, hyper-extended head position in children, pauses in breathing and startle responses during sleep.

Other symptoms of sleep apnea include loud snoring, obesity, lack of concentration, morning headaches, excessive sleepiness during the day, frequent visits to the bathroom at night, severe mood swings, low sex drive and a general lack of energy. Read the rest of this entry

Related Posts with Thumbnails